Intersaction

Intersaction

Intersaction was established by Michiel Schreurs and Joost Becker, operating from its headquarters in Laren, Netherlands. Schreurs, who also maintains a prominent research role in genetics and genomics at VIB-KU Leuven, brings an analytical discipline to the firm's investment process. The partnership includes former KPMG Deals partner Jeroen van Engelen, alongside partners Caspar Mütze and Wiet de Bruijn, creating a blend of scientific rigor and transaction advisory experience that defines the firm's approach to company building. The firm pursues a generalist strategy across buyout and growth equity, with specific expertise in management buy-ins and management buyouts. Intersaction typically targets mid-market companies in the Netherlands and broader European markets, taking control positions where its partners can deploy operational expertise alongside capital. The investment structure leans toward direct, concentrated positions rather than diversified fund commitments — a posture that aligns with the partnership's hands-on operational model. Intersaction maintains active memberships in ACG Holland and the international M&A advisory network M&A Worldwide, extending its sourcing reach beyond the domestic Dutch market. The partner group's combined background in corporate finance, entrepreneurship, and academic research creates an unusual talent pool for a firm of its scale. The firm runs a lean structure without disclosed satellite offices, relying on its network affiliations for cross-border deal origination rather than a multi-jurisdiction physical footprint. The firm's structural differentiation lies in the convergence of scientific and financial operating models. Schreurs's dual career — running an investment firm while maintaining active research obligations at one of Europe's leading life sciences institutes — produces a governance architecture where investment decisions are filtered through a researcher's evidentiary lens. This hybrid professional identity is rare among mid-market European investment firms, where founding partners typically exit prior careers rather than sustaining parallel institutional roles.